🔎 Trials Near Me

Gara Jalqabaatti › Myelofibrosis › Missouri › St. Louis

Qorannoo klinikaalii Myelofibrosis St. Louis, MO keessatti

Qorannoo 8 Myelofibrosis f St. Louis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Namoota walitti qabaa jiraSadarkaa 1/2
  • Washington University of Medicine, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Namoota walitti qabaa jiraSadarkaa 3
  • Washington University School of Medicine, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07623161

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Washington University St.Louis, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05320198

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

Namoota walitti qabaa jiraSadarkaa 1
  • Washington University School of Medicine, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06343805

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Washington University School of Medicine, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694

Therapeutic RSK1 Targeting in Myelofibrosis

Namoota walitti qabaa jiraSadarkaa 1
  • Washington University School of Medicine, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT07379125

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Washington University School of Medicine, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, St Louis
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Myelofibrosis magaalota biroo keessatti

Qorannoo biroo St. Louis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.